T cell injection targeting CD7 chimeric antigen receptor
PA-CART-3-17-001
Unknown small_molecule active
Quick answer
T cell injection targeting CD7 chimeric antigen receptor for T-ALL is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- T-ALL
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active